Enfortumab vedotin and pembrolizumab with surgery significantly improve outcomes in cisplatin-ineligible MIBC patients, ...
Pfizer and Japanese firm Astellas' drug Padcev, combined with Merck's Keytruda, lowered the risk of tumor recurrence, ...
The Hearty Soul on MSN
Cosmetic Doctor Conducts Self-Experiment with Botox - One Side of Her Face Tells All
Deciding whether to get Botox can feel confusing, especially when marketing claims and results don't always match. That is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback